ARISE
ARISE
Our newest addition to the END Fund is the Accelerate Resilient, Innovative, and Sustainable Elimination of NTDs Fund, known as the ARISE Fund. It is the second phase of a direct philanthropic response to the UK FCDO funding cuts to NTDs in 2021.
ARISE is the second phase of a direct philanthropic response to the UK Foreign Commonwealth and Development Office’s (FCDO) funding cuts to NTD’s in 2021.A first phase of ARISE provided funds for the most critical NTD program activities across 16 countries.
This second phase of ARISE, spans 3.5 years (2022 – 2025) and directly invests in Burkina Faso, Ethiopia, Kenya, South Sudan and Senegal with an emphasis on sustainability and a focus on country leadership which are the key in ingredients to accelerating progress towards the elimination of NTD’s.
Liben Omer Farah (right) performing a TT (trachomatous trichiasis) surgery on Hasan Abdi, 70 in Somali region, Ethiopia. He has conducted over 600 surgeries in the Somali Region, Ethiopia in the past three years.
Photo credit: Meseret Argaw
ABOUT ARISE
The ARISE Fund invests in these five countries’ (Burkina Faso, Ethiopia, Kenya, South Sudan, and Senegal) efforts to develop resource mobilization strategies, and strengthen the leadership and capacity of decision makers who represent communities affected by NTDs.
It employs a philosophy of co-financing programs with governments in order to integrate NTD program delivery within existing health systems. Each country has designed its own multi-year plan to best achieve the elimination of a number of identified NTD’s, a plan the END Fund supports the work to meet objectives of alongside selected and dedicated partners.
ARISE’S IMPACT
711093
TREATMENTS
PROVIDED
16100000
VALUE OF TREATMENTS in $
3380
HEALTH WORKERS TRAINED
856
SURGERIES PERFORMED